Infectious Diseases (except HIV/AIDS)
Showing page 162 of 716 pages of list content
-
BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants
This article's authors -
Influencing factors of Anti-SARS-CoV-2-Spike IgG antibody titres in healthcare workers â A cross-section study
This article's authors -
High but Short-lived anti-SARS-CoV2 neutralizing, IgM, IgA, and IgG levels among mRNA-vaccinees compared to naturally-infected participants
This article's authors -
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
This article's authors -
10.4 Million Children Affected by COVID-19-associated Orphanhood and Caregiver Death: An Imperative for Action
This article's authors -
Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
This article's authors -
Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting
This article's authors -
Routine Saliva Testing for SARS-CoV-2 in Children: Partnering with Childcare Centers in the Greater New Haven Community
This article's authors -
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern
This article's authors -
Clinical and Virological Features of patients hospitalized with different types of COVID-19 vaccination in Mexico City
This article's authors